B+
Bull case
20%
Probability
Target price
$19.60
+2.7% vs current
FONR
FonarANasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-02
AI scenario view
RankAlpha Sentiment CodexPost-earnings T+3Most likely
B
Base case
55%
Probability
Target price
$18.90
-1.0% vs current
B-
Bear case
25%
Probability
Target price
$17.40
-8.9% vs current
AI sentiment snapshot
Latest data as of 2026-05-19
Recent news sentiment (30D)
-26.5
Negative
Company
-
Unavailable
Macro
-26.5
Negative
Pulse
-
Unavailable
Sentiment proxy
+46.5
Score
AI commentary
T3 follow-up is cautious. The earnings release was mixed to weak on profitability and cash flow, while scan volume and MRI footprint metrics improved. There is no confirmed analyst revision set here, so the main read-through is muted market reaction and continued merger-arb framing rather than a new operating thesis.
RankAlpha Sentiment Codex - 2026-05-19
Open post-earnings memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-05-11eventFiscal Q3 2026 earnings showed weaker profitability but steadier scan volumeMedium impact
The May 11 earnings release and 10-Q showed Q3 revenue down 3% year over year to $26.5 million, operating income down 33% to $2.4 million, net income down 25% to $2.3 million, and diluted EPS down 35% to $0.24. Nine-month revenue rose to $78.1 million, but nine-month operating income and net income fell, and operating cash flow declined to $3.4 million from $7.0 million. Offsetting that, HMCA scan volume was a record 55,660 in the quarter, up 1.8% year over year, and 165,612 over nine months, up 3.0%. [#8-K-2026-05-12] [#10-Q-2026-05-11]
2026-05-28catalystTake-private process and deal mechanics keep the stock in merger-arb modeMedium impact
The 10-Q says the special meeting is scheduled for May 28, 2026, the merger remains subject to stockholder approval and closing conditions, and the company could owe a termination fee if the transaction fails under certain circumstances. The filing also notes no alternative financing arrangements have been made if contemplated financing is unavailable. That keeps valuation anchored to deal mechanics rather than a standalone rerating. [#10-Q-2026-05-11]
2026-12-31catalystHMCA footprint expansion and scanner additions support underlying operating stabilityMedium impact
Management said HMCA now manages 45 MRI scanners, scan volume rose sequentially and year over year, and growth has been helped by high-field MRI additions at existing sites; the company also said it expects to manage a new MRI center in Nassau County before the end of fiscal 2026. That supports the underlying operating base, even if the take-private process limits public-market rerating. [#8-K-2026-05-12]
Recommendation
N/A
No formal recommendation provided.
As of 2026-05-19 • Updated nightlySource: Internal modelMethodology